Archive for the ‘Disease’ Category

Patient satisfaction is a subjective measure and depends on the patient’s preferences and perceived expectations. In this small survey, the patients demonstrated an overall high level of satisfaction with counselling services provided by both pharmacists and nurses. Patients expressed greater satisfaction with the information about medication side effects that was provided by pharmacists, and there […]

A total of 100 subjects were recruited, 50 of whom were counselled by pharmacists and 50 by nurses. All participants completed the initial interviews over a period of 1 month. The overall mean scores for the level of satisfaction with counselling were not significantly different between patients counselled by pharmacists and those counselled by nurses […]

Patient Selection Ambulatory patients with latent TB infection and active extrapulmonary disease with Mycobacterium tuberculosis, as well as those with atypical mycobacterial disease, were surveyed for satisfaction with counselling services. Patients with active pulmonary TB were excluded because air exchange in the pharmacy was inadequate (as defined by the Canadian Standards Association). Each patient was […]

INTRODUCTION Although overall rates of tuberculosis (TB) in Canada are low, the previous gradual decline in disease rates has reached a plateau. In both the United States and Canada certain groups remain at high risk for TB, most notably foreign-born residents, who represent over 50% of cases. Other groups at high risk include Canadian-born Aboriginal […]

An after-marketing study using a database of spontaneous SSRI adverse drug reaction reports showed that the reporting rate of withdrawal reactions in adult patients was 10 times higher (0.3 per thousand) than with sertraline (0.03 per thousand), and 100 times higher than with fluoxetine (0.002 per thousand). Based on the extremely limited number of cases […]

The use of selective serotonin reuptake inhibitors (fluoxetine, sertraline) to treat depression during pregnancy has become increasingly popular, in part due to studies that indicate that these antidepressants are unlikely to be teratogenic at therapeutic doses. However, case reports have appeared sporadically in medical literature describing withdrawal symptoms in neonates whose mothers took these medications […]

The ALLHAT study validated current national hypertension treatment guidelines by demonstrating that using chlorthali-done as the initial treatment was as effective as using a drug from one of the alternative classes of antihypertensive agents known as ACE-inhibitors (lisinopril) and a calcium-channel blocker (amlopidine) in decreasing blood pressure and reducing the incidence of fatal coronary heart […]